^
BRAF V600E
Hairy Cell Leukemia
trametinib + dabrafenib
Sensitive
:
C3
Blood - 1 week - (New C3)
No biomarker
Hairy Cell Leukemia
cladribine
Sensitive
:
A1
No biomarker
Hairy Cell Leukemia
moxetumomab pasudotox
Sensitive
:
A1
No biomarker
Hairy Cell Leukemia
rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
vemurafenib + rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
pentostatin
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
rituximab / hyaluronidase
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
vemurafenib
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
ibrutinib
Sensitive
:
A2
BRAF V600E
Hairy Cell Leukemia
dabrafenib
Sensitive
:
C2
BRAF V600
Hairy Cell Leukemia
vemurafenib
Sensitive
:
C2
BRAF V600E
Hairy Cell Leukemia
vemurafenib
Sensitive
:
C2
BRAF V600E
Hairy Cell Leukemia
dabrafenib + rituximab
Sensitive
:
C3
TP53 mutation
Hairy Cell Leukemia
rituximab + cladribine
Resistant
:
C3
MYD88 L265P + BRAF V600E
Hairy Cell Leukemia
rituximab
Sensitive
:
C4
KRAS mutation
Hairy Cell Leukemia
vemurafenib
Resistant
:
C4